NAD finds support for Kinoko AHCC claims
This article was originally published in The Tan Sheet
The mushroom-derived ingredient active hexose correlated compound shows immune-support benefits, though Quality of Life Labs should tweak its advertising language for Kinoko AHCC and Kinoko AHCC Gold, the National Advertising Division finds. The Purchase, N.Y.-based firm should clarify that data showing improved immune response and enhanced macrophage and T-cell activity are associated with the ingredient and not its products, the Council of Better Business Bureaus unit said May 28. Additionally, Quality of Life should revise its claim that the supplement is supported by "over 80 research studies," since NAD found the actual number was much lower, and should disclose that the immune benefits studied occurred in individuals with compromised immune systems. The company praised NAD's conclusions as "accurate and insightful" and said it will comply
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.